Literature DB >> 1644840

Expression and assembly of a functional E1 component (alpha 2 beta 2) of mammalian branched-chain alpha-ketoacid dehydrogenase complex in Escherichia coli.

J R Davie1, R M Wynn, R P Cox, D T Chuang.   

Abstract

We have expressed an active recombinant E1 decarboxylase component of the mammalian branched-chain alpha-ketoacid dehydrogenase complex in Escherichia coli by subcloning mature E1 alpha and E1 beta subunit cDNA sequences into a bacterial expression vector. To permit affinity purification under native conditions, the mature E1 alpha subunit was fused with the affinity ligand E. coli maltose-binding protein (MBP) through an endoprotease Factor Xa-specific linker peptide. When co-expressed, the MBP-E1 alpha fusion and E1 beta subunits were shown to co-purify as a MBP-E1 component that exhibited both E1 activity and binding competence for recombinant branched-chain E2 component. In contrast, in vitro mixing of individually expressed MBP-E1 alpha and E1 beta did not result in assembly or produce E1 activity. Following proteolytic removal of the affinity ligand and linker peptide with Factor Xa, a recombinant E1 species was eluted from a Sephacryl S-300HR sizing column as an enzymatically active 160-kDa species. The latter showed 1:1 subunit stoichiometry, which was consistent with an alpha 2 beta 2 structure. The recovery of this 160-kDa recombinant E1 species (estimated at 0.07% of total lysate protein) was low, with the majority of the recombinant protein lost as insoluble aggregates. Our findings suggest that the concurrent expression of both E1 alpha and E1 beta subunits in the same cellular compartment is important for assembly of both subunits into a functional E1 alpha 2 beta 2 heterotetramer. By using this co-expression system, we also find that the E1 alpha missense mutation (Tyr-393----Asn) characterized in Mennonites with maple syrup urine disease prevents the assembly of soluble E1 heterotetramers.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1644840

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  Maple syrup urine disease 1954 to 1993.

Authors:  F Peinemann; D J Danner
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

2.  Biochemical and molecular characterization of the Clostridium magnum acetoin dehydrogenase enzyme system.

Authors:  N Krüger; F B Oppermann; H Lorenzl; A Steinbüchel
Journal:  J Bacteriol       Date:  1994-06       Impact factor: 3.490

3.  Acetoin catabolic system of Klebsiella pneumoniae CG43: sequence, expression, and organization of the aco operon.

Authors:  W L Deng; H Y Chang; H L Peng
Journal:  J Bacteriol       Date:  1994-06       Impact factor: 3.490

4.  Reconstitution of mammalian excision repair activity with mutant cell-free extracts and XPAC and ERCC1 proteins expressed in Escherichia coli.

Authors:  C H Park; A Sancar
Journal:  Nucleic Acids Res       Date:  1993-11-11       Impact factor: 16.971

5.  Identification and molecular characterization of the aco genes encoding the Pelobacter carbinolicus acetoin dehydrogenase enzyme system.

Authors:  F B Oppermann; A Steinbüchel
Journal:  J Bacteriol       Date:  1994-01       Impact factor: 3.490

6.  Molecular and biochemical basis of intermediate maple syrup urine disease. Occurrence of homozygous G245R and F364C mutations at the E1 alpha locus of Hispanic-Mexican patients.

Authors:  J L Chuang; J R Davie; J M Chinsky; R M Wynn; R P Cox; D T Chuang
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

7.  Stable correction of maple syrup urine disease in cells from a Mennonite patient by retroviral-mediated gene transfer.

Authors:  H Koyata; R P Cox; D T Chuang
Journal:  Biochem J       Date:  1993-11-01       Impact factor: 3.857

8.  Cloning and sequencing of a cluster of genes encoding branched-chain alpha-keto acid dehydrogenase from Streptomyces avermitilis and the production of a functional E1 [alpha beta] component in Escherichia coli.

Authors:  D D Skinner; M R Morgenstern; R W Fedechko; C D Denoya
Journal:  J Bacteriol       Date:  1995-01       Impact factor: 3.490

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.